Oleg E Akilov (O Akilov, Oleg Akilov)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Blood advances

The British journal of dermatology

Cells

Experimental dermatology

University of Pittsburgh School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh School of Medicine Jul 01 2015

United States

Assistant Professor :: Dermatology

Publications

Tony T Jiang, Oleg Kruglov, Oleg E Akilov
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon. Blood advances 8 (10) (2024)
Tony T Jiang, Oleg Kruglov, Oleg E Akilov
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon. Blood advances 8 (10) (2024)
Tony T Jiang, Oleg Kruglov, Oleg E Akilov
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon. Blood advances 8 (10) (2024)
Christopher Bazewicz, Nicolena Verardi, Oleg E Akilov
Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution Study. The oncologist (2024)
Christopher Bazewicz, Nicolena Verardi, Oleg E Akilov
Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution Study. The oncologist 29 (3) (2024)
Tony T Jiang, Oleg Kruglov, Oleg E Akilov
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon. Blood advances (2024)
Amy Xiao, Colleen J Beatty, Sonal Choudhary, Oleg E Akilov
CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule. Hematology reports 15 (3) (2023)
Oleg E Akilov
What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome? Cells 12 (18) (2023)
Steven M Horwitz, Julia J Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H Kim, Pietro Quaglino, Pier Luigi Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E Akilov, Larisa Geskin, Jose Antonio Sanches, Pablo Luis Ortiz-Romero, Michael Weichenthal, David C Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, Henry Miles Prince
Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. Blood advances 5 (23) (2022)
Tony T Jiang, Oleg Kruglov, Larisa J Geskin, Oleg E Akilov
Repetitive expanded T-cell receptor clonotypes impart the classic T helper 2 Sézary cell phenotype. The British journal of dermatology 187 (2) (2022)
Amy Xiao, Oleg E Akilov
Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma. Cells 11 (22) (2022)
Raman Preet Kaur Gill, Jennifer Gantchev, Amelia Martínez Villarreal, Brandon Ramchatesingh, Elena Netchiporouk, Oleg E Akilov, Niels Odum, Robert Gniadecki, Sergei B Koralov, Ivan V Litvinov
Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma. Cells 11 (4) (2022)
Tony T Jiang, Oleg Kruglov, Gloria H Y Lin, Angela Minic, Kimberly Jordan, Robert A Uger, Mark Wong, Yaping Shou, Oleg E Akilov
Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4+ BTLA+ T Cells in Tumor Microenvironment of Mycosis Fungoides. Cancers 13 (23) (2021)
Oleg Kruglov, Lisa D S Johnson, Angela Minic, Kimberly Jordan, Robert A Uger, Mark Wong, Eric L Sievers, Yaping Shou, Oleg E Akilov
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides. Cancer immunology, immunotherapy : CII (2021)
Stephen M Ansell, Michael B Maris, Alexander M Lesokhin, Robert W Chen, Ian W Flinn, Ahmed Sawas, Mark D Minden, Diego R Villa, Mary-Elizabeth M Percival, Anjali S Advani, James M Foran, Steven M Horwitz, Matthew G Mei, Jasmine Zain, Kerry J Savage, Christiane Querfeld, Oleg E Akilov, Lisa D S Johnson, Tina Catalano, Penka S Petrova, Robert A Uger, Eric L Sievers, Anca Milea, Kathleen Roberge, Yaping Shou, Owen A O'Connor
Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)
E Hodak, Shany Sherman, E Papadavid, M Bagot, C Querfeld, Pietro Quaglino, H M Prince, P L Ortiz-Romero, R Stadler, R Knobler, Emmanuella Guenova, T Estrach, A Patsatsi, Yael A Leshem, H Prague-Naveh, E Berti, S Alberti-Violetti, R Cowan, C Jonak, Vasiliki A Nikolaou, C Mitteldorf, Oleg E Akilov, Larisa J Geskin, R Matin, Marie Beylot-Barry, L Vakeva, J A Sanches, O Servitje, S Weatherhead, M Wobser, J Yoo, M Bayne, A Bates, G Dunnill, M Marschalko, A M Buschots, Ulrike Wehkamp, F Evison, E Hong, Iris Amitay-Laish, R Stranzenbach, M Vermeer, R Willemze, W Kempf, L Cerroni, Sean Whittaker, Y H Kim, Julia J Scarisbrick, null null
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. The British journal of dermatology 184 (3) (2020)
Lisa D S Johnson, Swati Banerjee, Oleg Kruglov, Natasja Nielsen Viller, Steven M Horwitz, Alexander Lesokhin, Jasmine Zain, Christiane Querfeld, Robert Chen, Craig Okada, Ahmed Sawas, Owen A O'Connor, Eric L Sievers, Yaping Shou, Robert A Uger, Mark Wong, Oleg E Akilov
Targeting CD47 in Sézary syndrome with SIRPαFc. Blood advances 3 (7) (2020)
Kevin Molloy, C Jonak, F J S H Woei-A-Jin, E Guenova, A M Busschots, A Bervoets, E Hauben, R Knobler, S Porkert, C Fassnacht, R Cowan, E Papadavid, Marie Beylot-Barry, E Berti, S Alberti Violetti, T Estrach, R Matin, Oleg E Akilov, L Vakeva, M Prince, A Bates, M Bayne, R Wachsmuch, U Wehkamp, M Marschalko, O Servitje, D Turner, S Weatherhead, M Wobser, J A Sanches, P McKay, D Klemke, C Peng, A Howles, J Yoo, F Evison, J Scarisbrick
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. The British journal of dermatology 182 (3) (2019)
David Lemchak, Swati Banerjee, Shaunak S Digambar, Brian L Hood, Thomas P Conrads, Jaroslaw Jedrych, Larisa Geskin, Oleg E Akilov
Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome. Experimental dermatology 27 (2) (2017)
Dinesh Pradhan, Jaroslaw J Jedrych, Jonhan Ho, Oleg E Akilov
Hypopigmented Mycosis Fungoides with Large Cell Transformation in a Child. Pediatric dermatology 34 (5) (2017)
Brittany Dulmage, Larisa Geskin, Joan Guitart, Oleg E Akilov
The biomarker landscape in mycosis fungoides and Sézary syndrome. Experimental dermatology 26 (8) (2017)

Oleg E Akilov.css-eqlu8i{font-size:small;padding-left:4px;} (O Akilov, Oleg Akilov)

Publication Activity (10 Years)

Top Topics

Top Venues

Oleg E Akilov (O Akilov, Oleg Akilov)